FI945694L - Substituoiden triatsolin sulfaattisuola, sen farmaseuttisia koostumuksia ja niiden käyttö terapiassa - Google Patents

Substituoiden triatsolin sulfaattisuola, sen farmaseuttisia koostumuksia ja niiden käyttö terapiassa Download PDF

Info

Publication number: FI945694L
Authority: FI; Finland
Prior art keywords: substituting; therapy; pharmaceutical compositions; sulfate salt; triazole
Prior art date: 1992-06-05

Application number

FI945694A

Other languages

English (en)

Swedish (sv)

Other versions

FI945694A0 (fi

FI106201B (fi

Inventor

Raymond Baker

Victor G Matassa

Kendal G Pitt

Leslie J Street

Alexander R Guiblin

Carole Olive

David E Storey

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-05

Filing date

1994-12-02

Publication date

1994-12-02

1992-06-05 Priority claimed from GB929211903A external-priority patent/GB9211903D0/en

1993-04-07 Priority claimed from GB939307306A external-priority patent/GB9307306D0/en

1994-12-02 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

1994-12-02 Publication of FI945694A0 publication Critical patent/FI945694A0/fi

1994-12-02 Publication of FI945694L publication Critical patent/FI945694L/fi

2000-12-15 Application granted granted Critical

2000-12-15 Publication of FI106201B publication Critical patent/FI106201B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

FI945694A 1992-06-05 1994-12-02 Menetelmä substituoidun triatsolin sulfaattisuolan valmistamiseksi FI106201B (fi)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB9211903		1992-06-05
GB929211903A GB9211903D0 (en)	1992-06-05	1992-06-05	Pharmaceutical composition
GB9301132		1993-01-21
GB9307306		1993-04-07
GB939307306A GB9307306D0 (en)	1993-04-07	1993-04-07	Therapeutic agents
PCT/GB1993/001132 WO1993025547A1 (en)	1992-06-05	1993-05-28	The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy

Publications (3)

Publication Number	Publication Date
FI945694A0 FI945694A0 (fi)	1994-12-02
FI945694L true FI945694L (fi)	1994-12-02
FI106201B FI106201B (fi)	2000-12-15

Family

ID=26301005

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
FI945694A FI106201B (fi)	1992-06-05	1994-12-02	Menetelmä substituoidun triatsolin sulfaattisuolan valmistamiseksi
FI20001776A FI20001776L (fi)	1992-06-05	2000-08-10	Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI20001777A FI20001777L (fi)	1992-06-05	2000-08-10	Substituoidun triatsolin sulfaattisuola ja sen farmaseuttisia koostumuksia

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
FI20001776A FI20001776L (fi)	1992-06-05	2000-08-10	Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI20001777A FI20001777L (fi)	1992-06-05	2000-08-10	Substituoidun triatsolin sulfaattisuola ja sen farmaseuttisia koostumuksia

Country Status (27)

Country	Link
US (1)	US5527817A (fi)
EP (1)	EP0573221B1 (fi)
JP (2)	JP2619197B2 (fi)
KR (1)	KR100286411B1 (fi)
CN (1)	CN1043532C (fi)
AT (1)	ATE165602T1 (fi)
AU (2)	AU659311B2 (fi)
BG (1)	BG61976B1 (fi)
CA (1)	CA2097208C (fi)
CZ (1)	CZ282060B6 (fi)
DE (1)	DE69318212T2 (fi)
DK (1)	DK0573221T3 (fi)
ES (1)	ES2116411T3 (fi)
FI (3)	FI106201B (fi)
HK (1)	HK1010050A1 (fi)
HU (1)	HUT71403A (fi)
IL (1)	IL105847A (fi)
LV (1)	LV12210B (fi)
MX (1)	MX9303373A (fi)
NO (1)	NO307420B1 (fi)
NZ (1)	NZ253210A (fi)
RO (1)	RO114326B1 (fi)
RU (1)	RU2130022C1 (fi)
SG (1)	SG50406A1 (fi)
SK (1)	SK279211B6 (fi)
UA (1)	UA27908C2 (fi)
WO (1)	WO1993025547A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69616335T2 (de) *	1995-07-11	2002-07-11	MERCK & CO., INC.	Ein triazolylmethyl-indol-ethylamin-bisulfat-salz
ZA965837B (en) *	1995-07-11	1997-01-31	Merck & Co Inc	A triazolylmethyl-indole ethylamine bisulfate salt
US6192882B1 (en) *	1997-02-24	2001-02-27	Aradigm Corporation	Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6349719B2 (en)	1997-02-24	2002-02-26	Aradigm Corporation	Formulation and devices for monitoring the efficacy of the delivery of aerosols
CA2348979A1 (en) *	1998-11-02	2000-05-11	Merck & Co., Inc.	Method of treating migraines and pharmaceutical compositions
CN100364991C (zh)	2001-08-15	2008-01-30	法玛西雅厄普约翰美国公司	2,4-二甲基-1h-吡咯-3-甲酰胺衍生物的苹果酸盐的晶体、其制备方法和其组合物
WO2006137083A1 (en) *	2005-06-20	2006-12-28	Natco Pharma Limited	Improved process for the preparation of rizatriptan benzoate
ES2270717B1 (es) *	2005-08-08	2008-03-01	Ragactives, S.L.	Procedimiento para la obtencion de derivados de triptamina.
WO2007054979A1 (en) *	2005-11-14	2007-05-18	Matrix Laboratories Ltd	Process for the large scale production of rizatriptan benzoate
CA2688463A1 (en) *	2007-06-04	2008-12-11	Generics [Uk] Limited	Process for the preparation of rizatriptan
CA3010568C (en)	2016-01-27	2023-10-17	Instar Technologies A.S.	Oromucosal nanofiber carriers for therapeutic treatment
WO2024144413A1 (ru) *	2022-12-28	2024-07-04	Общество С Ограниченной Ответственностью "Ферринг Продакшн"	Жидкая фармацевтическая композиция для назального введения, содержащая ризатриптан

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
GB9026998D0 (en) *	1990-12-12	1991-01-30	Glaxo Group Ltd	Medicaments
CZ283018B6 (cs) *	1991-02-01	1997-12-17	Merck Sharp And Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi

1993
- 1993-05-28 SK SK1479-94A patent/SK279211B6/sk unknown
- 1993-05-28 EP EP93304158A patent/EP0573221B1/en not_active Expired - Lifetime
- 1993-05-28 WO PCT/GB1993/001132 patent/WO1993025547A1/en active IP Right Grant
- 1993-05-28 CA CA002097208A patent/CA2097208C/en not_active Expired - Fee Related
- 1993-05-28 ES ES93304158T patent/ES2116411T3/es not_active Expired - Lifetime
- 1993-05-28 NZ NZ253210A patent/NZ253210A/en unknown
- 1993-05-28 DE DE69318212T patent/DE69318212T2/de not_active Expired - Fee Related
- 1993-05-28 CZ CZ943044A patent/CZ282060B6/cs not_active IP Right Cessation
- 1993-05-28 RO RO94-01910A patent/RO114326B1/ro unknown
- 1993-05-28 JP JP5127463A patent/JP2619197B2/ja not_active Expired - Fee Related
- 1993-05-28 AT AT93304158T patent/ATE165602T1/de not_active IP Right Cessation
- 1993-05-28 KR KR1019940704402A patent/KR100286411B1/ko not_active Expired - Fee Related
- 1993-05-28 HU HU9403478A patent/HUT71403A/hu unknown
- 1993-05-28 RU RU94046380/04A patent/RU2130022C1/ru not_active IP Right Cessation
- 1993-05-28 AU AU39875/93A patent/AU659311B2/en not_active Ceased
- 1993-05-28 DK DK93304158T patent/DK0573221T3/da active
- 1993-05-28 SG SG1996000374A patent/SG50406A1/en unknown
- 1993-05-28 UA UA94129126A patent/UA27908C2/uk unknown
- 1993-05-28 AU AU43372/93A patent/AU4337293A/en not_active Abandoned
- 1993-05-31 IL IL10584793A patent/IL105847A/en not_active IP Right Cessation
- 1993-06-04 MX MX9303373A patent/MX9303373A/es not_active IP Right Cessation
- 1993-06-05 CN CN93108728A patent/CN1043532C/zh not_active Expired - Fee Related
1994
- 1994-10-21 BG BG99132A patent/BG61976B1/bg unknown
- 1994-12-02 NO NO944656A patent/NO307420B1/no not_active IP Right Cessation
- 1994-12-02 FI FI945694A patent/FI106201B/fi active
- 1994-12-07 US US08/350,760 patent/US5527817A/en not_active Expired - Lifetime
1996
- 1996-08-30 JP JP8230809A patent/JP2972150B2/ja not_active Expired - Fee Related
1998
- 1998-09-05 HK HK98110478A patent/HK1010050A1/xx not_active IP Right Cessation
- 1998-10-26 LV LVP-98-237A patent/LV12210B/en unknown
2000
- 2000-08-10 FI FI20001776A patent/FI20001776L/fi unknown
- 2000-08-10 FI FI20001777A patent/FI20001777L/fi unknown

Also Published As

Publication number	Publication date
SK279211B6 (sk)	1998-08-05
DE69318212T2 (de)	1998-11-19
BG61976B1 (bg)	1998-11-30
NZ253210A (en)	1995-09-26
FI945694A0 (fi)	1994-12-02
ES2116411T3 (es)	1998-07-16
BG99132A (bg)	1995-07-28
AU659311B2 (en)	1995-05-11
FI106201B (fi)	2000-12-15
JPH09176155A (ja)	1997-07-08
CA2097208A1 (en)	1993-12-06
NO944656D0 (no)	1994-12-02
UA27908C2 (uk)	2000-10-16
HK1010050A1 (en)	1999-06-11
NO307420B1 (no)	2000-04-03
JP2619197B2 (ja)	1997-06-11
CN1089263A (zh)	1994-07-13
LV12210A (lv)	1999-01-20
FI20001776L (fi)	2000-08-10
SK147994A3 (en)	1995-07-11
RU2130022C1 (ru)	1999-05-10
AU3987593A (en)	1993-12-09
ATE165602T1 (de)	1998-05-15
IL105847A0 (en)	1993-09-22
EP0573221B1 (en)	1998-04-29
JPH0641121A (ja)	1994-02-15
RO114326B1 (ro)	1999-03-30
SG50406A1 (en)	1998-07-20
HU9403478D0 (en)	1995-02-28
RU94046380A (ru)	1996-12-10
EP0573221A1 (en)	1993-12-08
CA2097208C (en)	2005-02-08
HUT71403A (en)	1995-11-28
IL105847A (en)	1998-09-24
US5527817A (en)	1996-06-18
CN1043532C (zh)	1999-06-02
JP2972150B2 (ja)	1999-11-08
FI20001777L (fi)	2000-08-10
MX9303373A (es)	1995-01-31
AU4337293A (en)	1994-01-04
CZ282060B6 (cs)	1997-05-14
KR950701922A (ko)	1995-05-17
NO944656L (no)	1994-12-02
LV12210B (en)	1999-03-20
DK0573221T3 (da)	1998-10-07
DE69318212D1 (de)	1998-06-04
WO1993025547A1 (en)	1993-12-23
KR100286411B1 (ko)	2001-04-16
CZ304494A3 (en)	1995-09-13

Publication	Publication Date	Title
FI962589L (fi)	1996-08-20	2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
EE9700039A (et)	1997-08-15	Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
FI953479A0 (fi)	1995-07-18	1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI944600A0 (fi)	1994-10-03	Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI945198L (fi)	1994-11-04	Farmaseuttiset ja muut annosmuodot
FI952920L (fi)	1995-06-14	7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
FI945625L (fi)	1994-11-29	Indolokarbatsoli-imidit ja niiden käyttö
NO933434D0 (no)	1993-09-27	Piperidinderivater, deres fremstilling og anvendelse
FI955140L (fi)	1995-10-27	Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä
EE9600172A (et)	1997-06-16	Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI945694L (fi)	1994-12-02	Substituoiden triatsolin sulfaattisuola, sen farmaseuttisia koostumuksia ja niiden käyttö terapiassa
EE9700288A (et)	1998-04-15	Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
IL107133A0 (en)	1993-12-28	Piperidine derivatives,their preparation and their application in therapy
FI940186A0 (fi)	1994-01-14	9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
IL101617A0 (en)	1992-12-30	2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
FI956353L (fi)	1995-12-29	Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
FI954141L (fi)	1996-03-06	Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
FI961339L (fi)	1996-03-22	Triaryylieteenijohdannaiset käytettäväksi hoidossa
NO942228D0 (no)	1994-06-14	Ipsapiron-legemiddeltilberedning
FI942265L (fi)	1994-11-18	2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI940185L (fi)	1994-07-16	4-pyrimidinonijohdannaisten suoloja, niiden valmistus ja niiden käyttö terapiassa
FI941913L (fi)	1994-10-28	Kinolyylidihydropyridiiniestereitä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI952855L (fi)	1995-06-09	Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
HRP940225B1 (en)	2000-06-30	The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy